Obstetrics & Maternal Newborn Investigations (OMNI)
The EAGER Pilot Trial
Gestational diabetes mellitus (GDM) is a common pregnancy complication that can lead to various negative health outcomes for both mother/birthing parent and baby. Recent research suggests that induction of labour (procedures or drugs used to stimulate birth) between 37 and 41 weeks of pregnancy may reduce some of these risks compared to expectant management (waiting until labour begins on its own or prompting labour and/or delivery to occur earlier if medically necessary).
However, there is still limited research, and no agreement amongst medical experts on the benefits of inducing labor after 37 weeks in pregnancies affected by GDM.
WHY IS THIS STUDY BEING DONE?
The purpose of this study, called a pilot study or a feasibility study, is to test if it is reasonable to conduct a larger study to determine if induction of labour between 38 weeks + 0 days and 38 weeks + 6 days gestation reduces the risk of serious health problems among pregnant individuals with GDM and their infants, compared to expectant management.
WHO CAN PARTICIPATE?
You might be eligible if:
- You have been diagnosed with GDM in your current pregnancy
- You are pregnant with one baby
- You are planning to deliver at one of the following centres:
- The Ottawa Hospital, Ottawa
- Kingston Health Sciences Centre, Kingston
WHAT WILL HAPPEN DURING THIS STUDY?
If you decide to participate, you will be put into a group by chance (like flipping a coin) into one of the groups below.